Medicinal products that have been released for sale or distribution without the safety features in a Member State before the date in which this Regulation becomes applicable in that Member State, and are not repackaged or relabelled thereafter, may be placed on the market, distributed and supplied to the public in that Member State until their expiry date.
Art. 48 Regulation (EU) 2016/161
Transitional measures
In forcesince 2 Oct 2015